Hutch News

Hutch News

Stories tagged 'VIDD Research Interests'

Experimental herpes drug more effective than standard treatment

Pritelivir reduces viral shedding and lesions better than valacyclovir, study shows

Dec. 20, 2016 | By Mary Engel / Fred Hutch News Service

The results of the phase 2, randomized, double-blind trial published today in JAMA showed that when people with genital herpes took a daily oral dose of pritelivir, they reduced their rate of viral shedding by half compared to when they took valacyclovir. They also had fewer genital sores and less pain.

View story >


Renewed hope for halting HIV through vaccine

At International AIDS Conference, researchers are optimistic as two new HIV vaccine trials are set to explore different approaches for protection

July 19, 2016 | By Mary Engel / Fred Hutch News Service

At the International AIDS Conference in Durban, South Africa, researchers are optimistic as two new HIV vaccine trials are set to explore different approaches for protection.

View story >


Global AIDS conference returns to Africa: What's changed

The last time the International AIDS Conference was in Africa, AIDS denialism was at its height; two Fred Hutch leaders in the fight to end HIV talk about where we’ve been – and what’s next

July 18, 2016

The last time the International AIDS Conference was in Africa, AIDS denialism was at its height; two leaders in the fight to end HIV talk about where we’ve been – and what’s next.

View story >


Drug-filled vaginal ring protects women from HIV — when used correctly

Consistent use of ring protects against HIV infection by up to 92 percent, according to new analyses that measured the effectiveness of consistent vs. inconsistent use

July 18, 2016 | By Rachel Tompa and Mary Engel / Fred Hutch News Service

Consistent use of a vaginal ring filled with an antiviral drug protects against HIV infection by up to 92 percent, new analyses show.

View story >


Fred Hutch HIV cure program extended, expanded

DefeatHIV receives second five-year grant from NIH to research gene and cell therapies

July 13, 2016 | By Mary Engel / Fred Hutch News Service

DefeatHIV, co-led by Drs. Keith Jerome and Hans-Peter Kiem, was awarded a second five-year grant from NIH to research gene and cell therapies.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

June 17, 2016

Dr. Larry Corey receives commissioned portrait; Inaugural symposium honors Dr. Joel Meyers; Dr. Julie McElrath appointed as Joel D. Meyers Endowed Chair

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.